1. Home
  2. SOWG vs TSBX Comparison

SOWG vs TSBX Comparison

Compare SOWG & TSBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOWG
  • TSBX
  • Stock Information
  • Founded
  • SOWG 2010
  • TSBX 2015
  • Country
  • SOWG United States
  • TSBX United States
  • Employees
  • SOWG N/A
  • TSBX N/A
  • Industry
  • SOWG Packaged Foods
  • TSBX
  • Sector
  • SOWG Consumer Staples
  • TSBX
  • Exchange
  • SOWG Nasdaq
  • TSBX Nasdaq
  • Market Cap
  • SOWG 8.8M
  • TSBX 7.7M
  • IPO Year
  • SOWG N/A
  • TSBX 2023
  • Fundamental
  • Price
  • SOWG $0.80
  • TSBX $0.37
  • Analyst Decision
  • SOWG
  • TSBX Buy
  • Analyst Count
  • SOWG 0
  • TSBX 3
  • Target Price
  • SOWG N/A
  • TSBX $4.75
  • AVG Volume (30 Days)
  • SOWG 270.0K
  • TSBX 614.5K
  • Earning Date
  • SOWG 08-13-2025
  • TSBX 08-13-2025
  • Dividend Yield
  • SOWG N/A
  • TSBX N/A
  • EPS Growth
  • SOWG N/A
  • TSBX N/A
  • EPS
  • SOWG N/A
  • TSBX N/A
  • Revenue
  • SOWG $23,063,113.00
  • TSBX N/A
  • Revenue This Year
  • SOWG $6.81
  • TSBX N/A
  • Revenue Next Year
  • SOWG N/A
  • TSBX N/A
  • P/E Ratio
  • SOWG N/A
  • TSBX N/A
  • Revenue Growth
  • SOWG N/A
  • TSBX N/A
  • 52 Week Low
  • SOWG $0.52
  • TSBX $0.29
  • 52 Week High
  • SOWG $24.83
  • TSBX $3.05
  • Technical
  • Relative Strength Index (RSI)
  • SOWG 50.70
  • TSBX 57.04
  • Support Level
  • SOWG $0.75
  • TSBX $0.33
  • Resistance Level
  • SOWG $0.87
  • TSBX $0.38
  • Average True Range (ATR)
  • SOWG 0.07
  • TSBX 0.03
  • MACD
  • SOWG 0.00
  • TSBX 0.00
  • Stochastic Oscillator
  • SOWG 22.48
  • TSBX 93.44

About SOWG Sow Good Inc. Common Stock

Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups. The company also sells gluten-free products under the Sow Good brand. The company is developing a freeze-dried candy market and snack manufacturing to provide consumers with flavorful freeze-dried treats.

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Share on Social Networks: